Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

Edwards Lifesciences Receives FDA Approval for AUTUS Valve, the First Surgical ...

2 October 2026 · By · Wire by Fusion42

Published

2 October 2026

Topic

opportunities

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at biospace.com →

◆ Verified

Fusion42 · 3 October 2026 · Fusion42 review

Edwards Lifesciences has received FDA approval for the AUTUS Size-Adjustable Valve, the first surgical pulmonary valve designed specifically for pediatric patients, which can be expanded via a minimally invasive transcatheter procedure to reduce repeat open-heart surgeries.

This Wire brief sits within Fusion42's coverage of Medtech.

◆ ◆ The Wire takeaway

You need to prioritise partnerships with cardiac surgeons and paediatric cardiology centres as the door is open for surgical valve suppliers in congenital heart care. This approval redefines treatment paths and cuts the frequency of repeat surgeries, shifting clinical demand patterns.

◆ Coverage

1 source · 2 Oct 2026

◆ Related on Wire

◆ Topics

Medtechfda-approvalpediatric-cardiacsurgical-valvemedtechcongenital-heart